University of Georgia

Recent Events

News & Analysis

biotechnology and university of georgia - All News and Analysis

• S/L/A/M Collaborative Announces New Higher Education Projects

  - 2006-08-16

  GLASTONBURY, Conn. -- The S/L/A/M Collaborative, an architectural firm that specializes in education, science & technology, and health care, has been awarded three new campus projects from the State University of New York SUNY and one project from the University of Georgia. S/L/A/M Collaborative has been selected by SUNY...

  Tags: Benefits, Biotechnology, education, HEALTHCARE, SOFTWARE, University of Georgia

• Crop Tech

  - 2005-09-02

  Glyphosate Resistance Update Weed scientists in California and Georgia report two glyphosate- resistant weed populations.University of California UC researchers recently identified a horseweed population in Fresno County that's able to withstand four times the labeled rate of glyphosate. "The location where this population was identified had...

  Tags: Biotechnology, GIS, hybrid, PRODUCTIVITY, SOFTWARE, University of Georgia

• InsectiGen enters licensing arrangement with Pioneer Hi-Bred.(InsectiGen)

  - 2005-08-01

  InsectiGen (Athens, GA) announced that its patented BtBooster technology has been licensed by Pioneer Hi-Bred International, Inc., a subsidiary of DuPont, for use in making better pest-resistant crops. Terms of the agreement were not disclosed. Developed by University of Georgia Professor of Entomology, ...

  Tags: agreement, Biotechnology, British Telecommunications, professor, technology, University of Georgia

• ALNYLAM INITIATES RNAI THERAPEUTIC PROGRAM FOR PANDEMIC FLU.

  - 2005-07-01

  Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), Cambridge, Mass., a RNAi therapeutics company, has announced a collaboration with researchers from the University of Georgia to discover and develop a Direct RNAiTM therapeutic for the treatment and prevention of respiratory infection from newly emerging, highly pathogenic strains of influenza...

  Tags: Alnylam Pharmaceuticals Inc., Biotechnology, flu, influenza, outbreak, RNA, SECURITY, University of Georgia, virus

• Alnylam Initiates RNAi Therapeutic Program for Pandemic Influenza; Collaboration with Leading Flu Researchers at University of Georgia to Develop an RNAi-Based Prevention and Treatment for Newly Emerging, Highly Pathogenic Flu

  - 2005-05-25

  CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a leading RNAi therapeutics company, announced today a collaboration with researchers from the University of Georgia to discover and develop a Direct RNAiTM therapeutic for the treatment and prevention of respiratory infection from newly emerging, highly pathogenic strains of influenza flu virus. Alnylam...

  Tags: Alnylam Pharmaceuticals Inc., Biotechnology, collaboration, flu, influenza, outbreak, RNA, SECURITY, University of Georgia, virus